Friday, 22 February 2019

India News

  • Cadila arm acquires six brands from MSD pharma

    India |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2017

    Singapore: Indian pharma giant Cadila healthcare's arm Zydus Healthcare has acquired six brands from MSD Pharmaceuticals India Pvt. Ltd, the local arm of US-based Merck & Co Inc, for di...Read more

  • Indian Pharma industry to hire only qualified personnel now

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Dec, 2016

    Singapore: In order to bring the Indian Pharmaceutical industry at par with international standards, the Ministry of Health and Family Welfare will now seek only qualified candidates in the...Read more

  • Vietnam blacklists 39 Indian drug firms

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2016

    Singapore: Giant drug makers like Aurobindo Pharma, Cadila and Mcleods Pharmaceuticals are among 39 Indian firms that have been blacklisted by Vietnam for quality standard violations. The c...Read more

  • Everstone acquires majority stake in Rubicon Research

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Oct, 2016

    Singapore: The Everstone Group has bought a 70 percent stake in Mumbai-based Rubicon Research Pvt. Ltd., a pioneering drug delivery technology company in India, for a total outlay of Rs 220...Read more

  • Sayre Therapeutics announces distribution agreement with Cancer Genetics Inc

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2016

    Singapore: Sayre Therapeutics, today announced an exclusive distribution agreement with Cancer Genetics Inc.(CGI), a leading organization for enabling precision medicine for oncology throug...Read more

  • Is public health in India secure?

    India |  Opinion | By Aishwarya Venkatesh  | 0 Comment | 24 Oct, 2016

    Singapore: The country's national capital is reeling under one of the worst outbreaks of dengue and chikungunya this year. The cases of chikungunya and dengue are soaring and health authori...Read more

  • India requests 'Green Channel' for export of drugs to China

    India |  News | By BioSpectrum Bureau  | 0 Comment | 14 Oct, 2016

    Singapore: With a view to bridge the increasing trade gap between the two countries, Chinese vice Minister of finance and commerce Mr Wang Shouwen said that the country will act on the conc...Read more

  • Bharat Biotech's Zika vaccine to enter phase-I trials

    India |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2016

    Singapore: Giving a further boost to Modi governemt's Make in India initiative, India's Bharat Biotech recently announced that the company has completed pre-clinical studies on its novel Zi...Read more

  • Zydus Cadila, Takeda to co-develop vaccine for chikungunya

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2016

    Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vaccine for chikungunya. As per the terms the companies will jointly devel...Read more

  • India's resurgence as a clinical trial destination

    India |  News | By Aishwarya Venkatesh  | 0 Comment | 21 Sep, 2016

    Singapore: Factors such as technically competent workforce, large genetically diverse population, easy patient availability make India one of the most preferred destination for clinical tri...Read more

  • Eppendorf launches pipette calibration facility in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Bangalore: Eppendorf, a leading life science company that develops and sells instruments, consumables and services, launched a Mobile Pipette Calibration facility in Chennai. This was launc...Read more

  • Columbia Asia receives $101mn investment from Mitsui & Co.

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2016

    Singapore: Columbia Asia has announced it is receiving $101 million in investment from Mitsui & Co., Ltd. Columbia Asia, part of Seattle-based Columbia Pacific Management, has 27 hospi...Read more

  • Lupin's sNDA Antara Capsules receive FDA nod

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2013

    Singapore: Indian drug major Lupin Limited's New Drug Application Antara capsules have received the US drug regulator's approval. The US Food and Drug Administration (FDA) provided its fin...Read more

  • "Solve Ranbaxy merger case in two days"

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2014

    Singapore: Now there is another twist to the interesting tale of merger of once powerful indigenous company, Ranbaxy by Sun Pharmaceutical Industries. The Supreme Court of India has asked t...Read more

  • Glenmark develops first-of-its-kind antibody

    India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical development anti-OX40 monoclonal antibody. GBR 830.  The drug cand...Read more

  • Sanofi, Carlyle to buy Elder Pharma for $450 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian drug major Elder Pharmaceuticals in a deal worth $400-to-450 million, a...Read more

  • India's Assam to launch miracle TB drug

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2016

    Singapore: As per reports, the Indian state of Assam has become the first state in Asia to launch a new drug that can combat multi-drug resistant tuberculosis. The drug, Bedaquiline (BDQ) c...Read more

  • New genomes of malaria sequenced, vaccine to follow

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    A group of scientists working in India and the US has sequenced and annotated the genomes of four Plasmodium vivax strains collected from disparate geographic locations in West Africa, Sout...Read more



Survey Box

Is Asia Pacific anticipated to be the fastest growing blockchain in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls